AU3527495A - Use of muramyl peptide compounds - Google Patents
Use of muramyl peptide compoundsInfo
- Publication number
- AU3527495A AU3527495A AU35274/95A AU3527495A AU3527495A AU 3527495 A AU3527495 A AU 3527495A AU 35274/95 A AU35274/95 A AU 35274/95A AU 3527495 A AU3527495 A AU 3527495A AU 3527495 A AU3527495 A AU 3527495A
- Authority
- AU
- Australia
- Prior art keywords
- peptide compounds
- muramyl peptide
- muramyl
- compounds
- peptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Ophthalmology & Optometry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9419011 | 1994-09-21 | ||
| GB9419011A GB9419011D0 (en) | 1994-09-21 | 1994-09-21 | Use of muramyl peptide compounds |
| PCT/GB1995/002237 WO1996009063A1 (en) | 1994-09-21 | 1995-09-20 | Use of muramyl peptide compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU3527495A true AU3527495A (en) | 1996-04-09 |
Family
ID=10761674
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU35274/95A Abandoned AU3527495A (en) | 1994-09-21 | 1995-09-20 | Use of muramyl peptide compounds |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP0782454A1 (en) |
| JP (1) | JPH10506387A (en) |
| KR (1) | KR970706015A (en) |
| AU (1) | AU3527495A (en) |
| BG (1) | BG101325A (en) |
| CA (1) | CA2200570A1 (en) |
| CZ (1) | CZ86197A3 (en) |
| GB (1) | GB9419011D0 (en) |
| HU (1) | HUT77741A (en) |
| IL (1) | IL115391A0 (en) |
| SK (1) | SK36697A3 (en) |
| WO (1) | WO1996009063A1 (en) |
| ZA (1) | ZA957997B (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU6693396A (en) * | 1995-08-08 | 1997-03-05 | Allergan, Inc. | Method of increasing tear production by topical administration of muramyl peptide |
| DE10106852A1 (en) * | 2001-02-14 | 2002-09-05 | T Luger | Anti-inflammatory compounds |
| CN108785251B (en) * | 2018-01-23 | 2020-11-24 | 盛元医药广州有限公司 | Medicinal composition for eyes and preparation method and application thereof |
| BR112023018950A2 (en) | 2021-03-19 | 2024-02-27 | Icahn School Med Mount Sinai | COMPOUND, NANOBIOLOGICAL AND PHARMACEUTICAL COMPOSITIONS, METHODS FOR TREATING A CELL PROLIFERATION DISORDER, FOR TREATING SEPSIS AND FOR ACTIVATING A NOD2 RECEPTOR, PROCESS FOR MANUFACTURING A NANOBIOLOGICAL COMPOSITION AND KIT |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0026746B1 (en) * | 1979-10-02 | 1985-04-10 | Ciba-Geigy Ag | Combinatory compositions for use in a method for enhancing the activity of antibiotics, antibiotic preparations having enhanced activity and process for their production |
| EP0056560A1 (en) * | 1981-01-19 | 1982-07-28 | Ciba-Geigy Ag | Active antibiotic compositions, process for their manufacture and process for the antibiotic activity of antibiotics |
| EP0102319B1 (en) * | 1982-07-23 | 1987-08-19 | Ciba-Geigy Ag | Prophylactic and therapeutic use of muramyl peptides and their analogues against viral infections |
| AU6066390A (en) * | 1989-07-19 | 1991-02-22 | Upjohn Company, The | Peptides containing diamino-glycols as transition-state mimics |
| WO1993010148A1 (en) * | 1991-11-19 | 1993-05-27 | Peptech (Uk) Limited | Muramyl compounds for treatment of septic shock |
| US5679348A (en) * | 1992-02-03 | 1997-10-21 | Cedars-Sinai Medical Center | Immunotherapy for recurrent HSV infections |
| MX9301789A (en) * | 1992-04-03 | 1993-10-01 | Iaf Biochem Int | NEW LIPOPHILIC OLIGOPEPTIDES WITH IMMUNOMODULATING ACTIVITY. |
-
1994
- 1994-09-21 GB GB9419011A patent/GB9419011D0/en active Pending
-
1995
- 1995-09-20 AU AU35274/95A patent/AU3527495A/en not_active Abandoned
- 1995-09-20 JP JP8510688A patent/JPH10506387A/en active Pending
- 1995-09-20 CZ CZ97861A patent/CZ86197A3/en unknown
- 1995-09-20 KR KR1019970701823A patent/KR970706015A/en not_active Application Discontinuation
- 1995-09-20 WO PCT/GB1995/002237 patent/WO1996009063A1/en not_active Application Discontinuation
- 1995-09-20 CA CA002200570A patent/CA2200570A1/en not_active Abandoned
- 1995-09-20 SK SK366-97A patent/SK36697A3/en unknown
- 1995-09-20 EP EP95932084A patent/EP0782454A1/en not_active Withdrawn
- 1995-09-20 HU HU9800756A patent/HUT77741A/en unknown
- 1995-09-21 ZA ZA957997A patent/ZA957997B/en unknown
- 1995-09-21 IL IL11539195A patent/IL115391A0/en unknown
-
1997
- 1997-03-13 BG BG101325A patent/BG101325A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL115391A0 (en) | 1995-12-31 |
| WO1996009063A1 (en) | 1996-03-28 |
| GB9419011D0 (en) | 1994-11-09 |
| CZ86197A3 (en) | 1997-08-13 |
| CA2200570A1 (en) | 1996-03-28 |
| ZA957997B (en) | 1997-03-24 |
| EP0782454A1 (en) | 1997-07-09 |
| SK36697A3 (en) | 1997-11-05 |
| HUT77741A (en) | 1998-07-28 |
| JPH10506387A (en) | 1998-06-23 |
| KR970706015A (en) | 1997-11-03 |
| BG101325A (en) | 1998-01-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2805195A (en) | Therapeutic compounds | |
| GB9526560D0 (en) | Use of 2-Amino-Heterocycles | |
| IL113248A0 (en) | Use of alpha - 1c specific compounds | |
| AU4953796A (en) | Dipeptide compounds having ahpba structure | |
| AU2893595A (en) | Use of muramyl peptide compounds | |
| AU2131195A (en) | Prophenins - antibiotic peptides | |
| AU4224096A (en) | Use of phenylcyclohexylcarboxamides | |
| AU4399396A (en) | Compounds | |
| AU3527495A (en) | Use of muramyl peptide compounds | |
| GB9506372D0 (en) | New peptide compounds | |
| AU3856995A (en) | UCF116 Compounds | |
| AUPM489194A0 (en) | Peptides | |
| ZA978027B (en) | The use of muramyl peptides | |
| AU1798100A (en) | Use of peptide | |
| NZ295530A (en) | Preparation of 1-halo-3-trialkylsilanyl-benzenes | |
| AU4292496A (en) | Improved mutable composition | |
| AU1824195A (en) | Oral synthetic peptide preparation | |
| AU2301295A (en) | Guanidino-substituted compounds | |
| AU6476398A (en) | Novel peptides | |
| AU3040797A (en) | Preparation of alpha-fluoroketones | |
| AU3705597A (en) | Preparation of aminomethyl-phenylimidazoles | |
| GB9422764D0 (en) | Use of compound | |
| AUPM594094A0 (en) | Analysis of iridodial | |
| GB9418295D0 (en) | Preparation of indoloquinone compounds | |
| AUPO007296A0 (en) | New peptide compounds |